Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05621707
PHASE2

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Sponsor: Shanghai Chest Hospital

View on ClinicalTrials.gov

Summary

This is an investigator-initiated, single-arm, exploratory clinical study.The study population consisted of non-operative Locally Advanced Esophageal Cancer . The purpose of this study was to evaluate the efficacy and safety of Concurrent Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Patients With Locally-advanced Esophageal Squamous Cell Cancer.

Official title: A Phase 2 Trial of Concurrent Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Patients With Locally-advanced Esophageal Squamous Cell Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2022-11-02

Completion Date

2026-10

Last Updated

2026-02-02

Healthy Volunteers

No

Interventions

DRUG

chemotherapy combined with PD-1 inhibitors

Induction chemotherapy combined with PD-1 inhibitors followed with standard concurrent chemoradiotherapy

Locations (1)

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China